Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
Citations Over TimeTop 1% of 2004 papers
Abstract
Inorganic phosphate is essential for ECM mineralization and also as a constituent of important molecules in cellular metabolism. Investigations of several hypophosphatemic diseases indicated that a hormone-like molecule probably regulates serum phosphate concentration. FGF23 has recently been recognized as playing important pathophysiological roles in several hypophosphatemic diseases. We present here the evidence that FGF23 is a physiological regulator of serum phosphate and 1,25-dihydroxyvitamin D (1,25[OH]2D) by generating FGF23-null mice. Disruption of the Fgf23 gene did not result in embryonic lethality, although homozygous mice showed severe growth retardation with abnormal bone phenotype and markedly short life span. The Fgf23(-/-) mice displayed significantly high serum phosphate with increased renal phosphate reabsorption. They also showed an elevation in serum 1,25(OH)2D that was due to the enhanced expression of renal 25-hydroxyvitamin D-1alpha-hydroxylase (1alpha-OHase) from 10 days of age. These phenotypes could not be explained by currently known regulators of mineral homeostasis, indicating that FGF23 is essential for normal phosphate and vitamin D metabolism.
Related Papers
- → Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation(2008)92 cited
- → Secondary Hyperparathyroidism in X-Linked Hypophosphatemic Mice*(1982)40 cited
- → Parathyroid Hormone Effects on Serum 1,25-Dihydroxyvitamin D Levels in Patients with X-Linked Hypophosphatemic Rickets: Evidence for Abnormal 25-Hydroxyvitamin D-1-Hydroxylase Activity*(1982)85 cited
- → Heterogeneous response to PTH in aging rats: evidence for skeletal PTH resistance(1991)15 cited
- Plasma 1,25(OH)2D3 response to parathyroid hormone, cyclic adenosine monophosphate, and phosphorus depletion in the spontaneously hypertensive rat.(1986)